Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients
Clinical trial NCT02683083 · COMPLETED
Trial details
- NCT number
- NCT02683083
- Sponsor
- Precirix
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-02-05
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.